Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP53 and ovarian cancer.

Human mutation - 1 Mar 2003

Schuijer Monique, Berns Els M J J

Abstract excerpt

Ovarian cancer represents the fourth most frequent type of cancer among females and is the leading cause of death from gynecological cancer in the western world. This review describes gene alterations in ovarian cancer. Specific emphasis is placed on genetic alterations and the prevalence of TP53 (p53) gene alterations in the distinct biological ovarian tumors (benign, borderline, and malignant) and histological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA1 gene
Share to Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Ovarian Neoplasms

Share to Prognosis

Share to Survival Analysis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 12619114
DOI: 10.1002/humu.10181

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53 and ovarian cancer.PMID 12619114Read ↗

TP53 Mutations in Breast and Ovarian Cancer.Semantic proximity Read ↗

TP53 mutations in epithelial ovarian cancerSemantic proximity Read ↗

Cellular Mechanism of Gene Mutations and Potential Therapeutic Targets in Ovarian CancerSemantic proximity Read ↗

Complexity of the Genetic Background of Oncogenesis in Ovarian Cancer—Genetic Instability and Clinical ImplicationsSemantic proximity Read ↗

Determination of Both TP53 Mutation Status and the Amount of p53 Protein has Limited Diagnostic Importance for Patients with Ovarian Cancer.Semantic proximity Read ↗

The role of p53 mutation in BRCA1-associated ovarian cancer.Semantic proximity Read ↗

Ovarian cancer.Semantic proximity Read ↗

Molecular aspects of ovarian cancer.Semantic proximity Read ↗

Role of p53 and Rb in ovarian cancer.Semantic proximity Read ↗

Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours.Semantic proximity Read ↗

Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations.Semantic proximity Read ↗

TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.